Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113257643> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2113257643 endingPage "600" @default.
- W2113257643 startingPage "595" @default.
- W2113257643 abstract "Diabetes is a major health problem particularly in India. In spite of many drugs available, uncontrolled diabetes remains a challenge. Moreover, some of the antidiabetic drugs are on the verge of withdrawal due to adverse effects. So, there is an acute need for a new effective and safe drug. Present study was planned to evaluate anti-diabetic efficacy of Nishamalaki in diabetic wistar rats. Nishamalaki was prepared from powder of Curcuma longa and fresh juice of Emblica officinalis according to ayurvedic literature and administered with honey. Diabetes was induced in wistar rats by injection of 60 mg/kg of Streptozotocin and 110 mg/kg Nicotinamide IP. 30 rats showing blood glucose above 250 mg/dl were divided into 5 groups Group I(Control )-Saline, Group II(Control )- Vehicle honey, Group III – Nishamalaki Prophylactic, Group IV- Nishamalaki treatment & Group V- Pioglitazone, given orally for 30 days. Blood glucose levels checked at days 0, 15, 30 & Cholesterol on day 30. Nishamalaki treatment achieved significant (p<0.01) lowering of blood glucose in diabetic rats comparable to that of the Pioglitazone treated group. Nishamalaki also reduced serum cholesterol levels. Antidiabetic efficacy of Nishamalaki in diabetic rats is comparable to Pioglitazone. It has also improved the lipid profile in diabetic rats." @default.
- W2113257643 created "2016-06-24" @default.
- W2113257643 creator A5011167395 @default.
- W2113257643 creator A5022214526 @default.
- W2113257643 creator A5041800070 @default.
- W2113257643 creator A5045893939 @default.
- W2113257643 creator A5057999222 @default.
- W2113257643 creator A5066432821 @default.
- W2113257643 creator A5090200578 @default.
- W2113257643 date "2015-02-13" @default.
- W2113257643 modified "2023-09-23" @default.
- W2113257643 title "Evaluation of anti-diabetic activity of Nishamlaki on streptozotocin induced type II diabetic rats" @default.
- W2113257643 hasPublicationYear "2015" @default.
- W2113257643 type Work @default.
- W2113257643 sameAs 2113257643 @default.
- W2113257643 citedByCount "1" @default.
- W2113257643 countsByYear W21132576432015 @default.
- W2113257643 crossrefType "journal-article" @default.
- W2113257643 hasAuthorship W2113257643A5011167395 @default.
- W2113257643 hasAuthorship W2113257643A5022214526 @default.
- W2113257643 hasAuthorship W2113257643A5041800070 @default.
- W2113257643 hasAuthorship W2113257643A5045893939 @default.
- W2113257643 hasAuthorship W2113257643A5057999222 @default.
- W2113257643 hasAuthorship W2113257643A5066432821 @default.
- W2113257643 hasAuthorship W2113257643A5090200578 @default.
- W2113257643 hasConcept C126322002 @default.
- W2113257643 hasConcept C134018914 @default.
- W2113257643 hasConcept C181199279 @default.
- W2113257643 hasConcept C185592680 @default.
- W2113257643 hasConcept C197934379 @default.
- W2113257643 hasConcept C2777180221 @default.
- W2113257643 hasConcept C2777230291 @default.
- W2113257643 hasConcept C2777397205 @default.
- W2113257643 hasConcept C2778270857 @default.
- W2113257643 hasConcept C2778384471 @default.
- W2113257643 hasConcept C2779280383 @default.
- W2113257643 hasConcept C2779728014 @default.
- W2113257643 hasConcept C3017536533 @default.
- W2113257643 hasConcept C55493867 @default.
- W2113257643 hasConcept C555293320 @default.
- W2113257643 hasConcept C556039675 @default.
- W2113257643 hasConcept C71924100 @default.
- W2113257643 hasConcept C98274493 @default.
- W2113257643 hasConceptScore W2113257643C126322002 @default.
- W2113257643 hasConceptScore W2113257643C134018914 @default.
- W2113257643 hasConceptScore W2113257643C181199279 @default.
- W2113257643 hasConceptScore W2113257643C185592680 @default.
- W2113257643 hasConceptScore W2113257643C197934379 @default.
- W2113257643 hasConceptScore W2113257643C2777180221 @default.
- W2113257643 hasConceptScore W2113257643C2777230291 @default.
- W2113257643 hasConceptScore W2113257643C2777397205 @default.
- W2113257643 hasConceptScore W2113257643C2778270857 @default.
- W2113257643 hasConceptScore W2113257643C2778384471 @default.
- W2113257643 hasConceptScore W2113257643C2779280383 @default.
- W2113257643 hasConceptScore W2113257643C2779728014 @default.
- W2113257643 hasConceptScore W2113257643C3017536533 @default.
- W2113257643 hasConceptScore W2113257643C55493867 @default.
- W2113257643 hasConceptScore W2113257643C555293320 @default.
- W2113257643 hasConceptScore W2113257643C556039675 @default.
- W2113257643 hasConceptScore W2113257643C71924100 @default.
- W2113257643 hasConceptScore W2113257643C98274493 @default.
- W2113257643 hasIssue "4" @default.
- W2113257643 hasOpenAccess W2113257643 @default.
- W2113257643 hasRelatedWork W1527597199 @default.
- W2113257643 hasRelatedWork W1977485265 @default.
- W2113257643 hasRelatedWork W2036821800 @default.
- W2113257643 hasRelatedWork W2121898880 @default.
- W2113257643 hasRelatedWork W2141245998 @default.
- W2113257643 hasRelatedWork W2160894763 @default.
- W2113257643 hasRelatedWork W2188535879 @default.
- W2113257643 hasRelatedWork W2330289923 @default.
- W2113257643 hasRelatedWork W2737207544 @default.
- W2113257643 hasRelatedWork W2786137277 @default.
- W2113257643 hasRelatedWork W2914117771 @default.
- W2113257643 hasRelatedWork W2917047083 @default.
- W2113257643 hasRelatedWork W2945621167 @default.
- W2113257643 hasRelatedWork W2989138800 @default.
- W2113257643 hasRelatedWork W3153382520 @default.
- W2113257643 hasRelatedWork W3201973881 @default.
- W2113257643 hasRelatedWork W3214662075 @default.
- W2113257643 hasRelatedWork W2514922706 @default.
- W2113257643 hasRelatedWork W2596216260 @default.
- W2113257643 hasRelatedWork W3109264813 @default.
- W2113257643 hasVolume "6" @default.
- W2113257643 isParatext "false" @default.
- W2113257643 isRetracted "false" @default.
- W2113257643 magId "2113257643" @default.
- W2113257643 workType "article" @default.